We explore trends shaping the future of human lifespan—from aging clocks and regenerative medicine to the business models behind personalized health consulting. Whether you're an investor, biohacker, or simply curious about the future of aging, this conversation offers a clear-eyed look at what really matters. 

Supertrends: Can you describe what a longevity concierge does and how it differs from traditional healthcare services? 

Victor Björk: A Longevity Concierge, as I define it, is someone with a strong scientific background who supports others in optimizing their health and well-being. The focus is on offering independent, science-based guidance to access advanced treatments and emerging technologies that are often not yet adopted by mainstream healthcare providers. 

A Longevity Concierge isn't necessarily a medical doctor; they might be a biomedical scientist or another type of health science expert. The key distinction is that the service involves scientific consulting, not direct medical advice. 

Imagine you're a successful individual who wants more out of life—you want to benefit from the most advanced healthcare options available. You visit five prestigious "longevity clinics," all boasting impeccable credentials, AI integration, and precision medicine. Yet, they each recommend different tests and treatments. Who’s right? Who stands by the client to protect their interests? 

That’s where the Longevity Concierge comes in—providing independent oversight and a critical, science-informed risk-benefit analysis. This isn’t about being overly conservative. “Doing nothing” often leads to preventable deaths from heart disease, cancer, or dementia by age 80. Instead, clients want someone who can evaluate what truly constitutes good science, without bias or conflict of interest. 

You won’t get this level of personalized attention from a typical general practitioner. Few professionals have the combination of time, expertise, and objectivity to guide clients this way. 

Supertrends: What kind of clients typically seek your services? Are they high-net-worth individuals, biohackers, or people with specific health concerns? 

Victor Björk: There’s some overlap, but my clients are typically people of substance—those who value quality and long-term relationships. While the term “biohacker” is popular, it’s often a branding term for individuals interested in self-optimization. 

I prefer working on a retainer basis, building sustainable, highly personalized relationships with clients. I don’t offer a one-size-fits-all program; every engagement is tailored to the individual. 

Supertrends: How do longevity concierge services integrate with existing healthcare systems and biotech innovations? 

Victor Björk: Take the example of a client facing a specific disease. A longevity concierge can help identify the best doctors and researchers worldwide—and critically, evaluate them independently. It's naive to assume that one will always receive the best possible treatment at the local hospital, except in cases of relatively simple conditions. 

A longevity concierge stays up to date with the latest scientific literature and emerging adjuvant therapies. They provide clients with clear action points and connect them with relevant experts, including researchers involved in cutting-edge clinical trials. 

Importantly, the most effective providers for a particular condition are not always at top universities. The fields of longevity and medicine are deeply fragmented, with no centralized, unbiased source of truth. A person might survive a life-threatening illness by accessing a global expert—but face poor outcomes at a "good enough" local facility. Unfortunately, there’s no way to quantify how many lives are lost due to these systemic gaps. 

A truly skilled longevity concierge combines deep scientific curiosity with a broad, global network. Their role is to help clients access the best available options—whether experimental or validated—beyond what traditional systems can provide. 

For a certain kind of individual, this kind of support can be life-changing. Why settle for an undesirable fate, if 2025’s technology could prevent it? 

Supertrends: There are different levels of longevity management—lifestyle optimization, consumer diagnostics, longevity supplements, medical interventions, and experimental biotech. Which of these do you focus on most? 

Victor Björk: I’m most focused on experimental biotech, as that’s where the greatest potential gains lie. Clinical trials are already underway for interventions with broad applicability in human longevity. 

That said, all levels of intervention overlap to some degree. For instance, lifestyle optimization is critical for avoiding premature death—many people don’t make it to 85. But I’m not overly focused on obsessively tracking things like micronutrients or exact sleep metrics. If you exercise regularly, eat decently, and sleep well, there’s limited evidence that additional micromanagement adds more years. The body can tolerate a fair amount of “suboptimal” living—as long as it clears a certain threshold of health. 

Supertrends: In your experience, which longevity approach tends to have the biggest impact on lifespan and healthspan? 

Victor Björk: Psychological well-being: stress management, social connection, and enjoying life. These show up repeatedly in research, even if they’re harder to quantify scientifically. Chronic stress and elevated cortisol levels from dissatisfaction are profoundly aging. 

If I had to name a single intervention—at least in lab animals—it would be Rapamycin, an immunosuppressant originally developed for organ transplants. No other intervention comes close to its effects on lifespan extension in those models. 

Supertrends: How do you help clients balance proven longevity strategies (like exercise, diet, and sleep) with more cutting-edge interventions (like senolytics, gene therapies, or peptide treatments)? 

Victor Björk: Ideally, clients should track key biomarkers and health metrics at regular intervals—not necessarily daily, but consistently over time. This allows them to see objective evidence that a particular approach is working. 

I don’t give medical advice—I offer independent scientific consulting to help clients make informed decisions grounded in current research. 

Supertrends: What are the biggest longevity trends for 2025? 

Victor Björk: As of 2025, one of the strongest trends is the increasing development and use of biological aging clocks to quantify aging and health. While many current clocks still lack high accuracy—which hasn’t stopped marketers from promoting them—the potential for organ-specific and highly precise aging clocks is very real. 

We're also seeing continued progress in cellular reprogramming and senolytics, as in previous years. Another key trend is the rise of AI-powered drug discovery, which is very promising. However, my advice is to proceed with caution—it’s a space that requires rigor more than hype. 

Supertrends: Are we seeing a shift toward more preventive, AI-driven, or personalized approaches in longevity? 

Victor Björk: All of the above. The challenge is making sure clients are aware of what’s actually available. The most effective approach often involves combining interventions from multiple providers globally to achieve comprehensive health tracking. 

There’s a significant gap between what can be done today and what people realize is possible. Personalized longevity is advancing rapidly, but public awareness hasn’t caught up. 

Supertrends: Which new diagnostic tools or biomarkers are emerging as the most promising for predicting longevity? 

Victor Björk: I’m particularly interested in plasma proteomic clocks. They’re not fully mature yet, but they’re improving quickly. These tools hold promise in predicting neurodegenerative diseases in advance and tracking markers of cellular senescence. As these clocks evolve, they’ll help us intervene earlier and more precisely. 

Supertrends: How do you see AI and wearables transforming personalized longevity plans? 

Victor Björk: AI is only as useful as the quality of data and the way we choose to interpret it. I absolutely use AI—and I believe everyone in this field should—but never for final decisions. 

We still need human judgment. In longevity, as in medicine, there’s a need for thoughtful, case-by-case evaluation. AI is only as good as the data the way we choose to interpret the data and we have to be careful when interpreting it. I certainly use AI myself, (one should!) but never ever for any final decision or conclusion. I think we have to stay old-fashioned and use human judgement for quite some more time. AI is a tool, not a replacement for expert reasoning. 

Supertrends: With so many longevity supplements on the market, how do you separate hype from science? 

Victor Björk: Careful reviewing of the literature—though that can be very difficult at times. There's a lot of data in life sciences that's hard to replicate; reproducibility is a major issue in this field. 

Supertrends: Are there any popular longevity treatments that you believe are overrated? 

Victor Björk: NAD boosters, Resveratrol, and taking vitamins when one is not deficient are overrated. Also, being overly cautious or fearful about trace chemicals in the environment is often blown out of proportion. 

Supertrends: How do you balance evidence-based interventions with cutting-edge but unproven biotech innovations? 

Victor Björk: By applying a rigorous, scientific mindset—staying updated on new research while maintaining skepticism until interventions are backed by reproducible results. The key is understanding the risk-benefit ratio for each client and scenario. 

Supertrends: What’s one underrated longevity strategy that more people should pay attention to? 

Victor Björk: Stress management and emotional well-being. Cortisol and chronic psychological stress are incredibly aging—people often underestimate this compared to things like diet or exercise. 

Supertrends: Do you think longevity concierge services will become mainstream, or remain a niche for the ultra-wealthy? 

Victor Björk: It depends how one defines it. In my experience, people who can afford it don’t want a pre-packaged agenda—they want a high-quality, personalized service and a kind of “trusted friend” who provides independent, impartial advice across disciplines. I would describe myself as a Longevity Concierge who independently evaluates other providers. 

In the near future, I believe this will remain a premium service. The people I work with value trust, and that’s not something you get from an AI chatbot charging a few dollars a month. Apart from accuracy, whose agenda would that bot be running? Would it be biased toward certain doctors or treatments in an evolving marketplace of thousands of competing providers? And what about keeping up with new science? This kind of trust and discernment is still very human. 

As for lower-cost versions for the general public—it all comes down to how one defines a concierge. If a family physician tells you to exercise more, is that a concierge service? 

Ultimately, it’s a question of how far a person is willing to go to access the best that science and medicine have to offer. That level of dedication requires investment. 

There’s incredible scientific progress happening in labs around the world. At the same time, there’s a lot of noise and unscientific hype—especially from “longevity influencers.” There’s a real gap to be filled here. And ultimately, the true value is trust. Even if you’re the most knowledgeable expert, people choose to work with you because they trust you. 

Supertrends: How do you see the business model of longevity concierge services evolving over the next 5–10 years? 

Victor Björk: I think we’ll see more players entering the field—some good, some not so good. This will only increase the demand for highly personalized and impartial services. 

Meanwhile, both diagnostics and treatment technologies will continue to improve. But at the same time, hype around certain treatments—and influencers spreading scientifically inaccurate information—will also increase. That’s why discerning, science-based guidance will be more critical than ever. 

Supertrends: Which longevity-focused biotech sectors do you think are most promising for investors—diagnostics, regenerative medicine, AI-driven health optimization, or something else? 

Victor Björk: Diagnostics are the most actionable in the short term. We're seeing exciting developments in quantifying aging and detecting diseases early. 

AI-driven health optimization can be useful for managing specific diseases, but I think it can be taken too far—especially when it comes to things like micronutrient tracking or over-optimizing sleep. People want to enjoy life, and there’s not much evidence that hyper-optimizing already decent habits (like diet, exercise, and sleep) will significantly extend life for someone who’s already healthy and likely to live into their 90s. 

Regenerative medicine, however, holds the greatest long-term potential—both in terms of human health and profitability. But it requires patience, since developing a drug from discovery to approval typically takes around 15 years. 

It’s also important to recognize that there’s no unified definition of “aging” as a target or framework. A biotech company may be doing transformative longevity work but not label itself as a “longevity startup.” Conversely, some may use the branding without substance. 

That’s what makes scouting and evaluating startups so interesting—there are a lot of hidden gems out there that could, in 10–20 years, become global leaders in the field. Identifying them takes deep expertise and real passion. 

So, investors need to strike a balance between short-term, actionable opportunities and long-term breakthroughs that will eventually intervene in the core biology of aging. 

Final considerations 

The future of longevity is as much about trust and independent guidance as it is about science and technology. As Victor Björk reminds us, navigating the frontier of human health requires not only data and diagnostics, but also discernment. In a world of accelerating biotech and conflicting claims, having a knowledgeable, impartial ally may prove to be one of the most powerful longevity tools of all. 

Whether longevity concierge services remain a niche or scale more broadly, one thing is clear: the demand for credible, personalized, and science-backed health strategies is only growing.